弯曲转子间内翻截骨术与全髋关节置换术治疗50岁以下股骨头坏死比较
本研究比较了弯曲转子间内翻截骨术(CVO)与全髋关节置换术(THA)治疗50岁以下股骨头坏死(ONFH)患者的临床结局。共纳入105例患者(CVO组59例65髋,THA组46例56髋),随访约10年。结果显示两组在功能评分、并发症率及10年生存率方面相当,严格掌握CVO适应证可长期维持髋关节功能与患者满意度。
要点
- CVO与THA在50岁以下ONFH患者中10年功能结局相当。
- 两组并发症率分别为3%和7%,10年生存率分别为91.8%和97.7%。
- 严格掌握CVO适应证可达到与THA相当的长期满意效果。
核心结论
- 对于50岁以下ONFH患者,CVO与THA在平均10年随访后功能结局、生存率和运动活动相当。
- 严格掌握CVO适应证有助于长期维持与THA等效的髋关节功能和患者满意度。
研究设计与样本
- 比较性研究,纳入105例ONFH患者:CVO组59例(65髋),THA组46例(56髋)。
- 评估工具包括Harris髋关节评分(HHS)、Short Form-36、Oxford髋关节评分、日本骨科协会髋关节疾病评估问卷(JOA Hip-Disease Evaluation Questionnaire)、加州大学洛杉矶分校(UCLA)评分,以及并发症率和生存率。
主要发现
- 术前HHS在CVO组显著高于THA组(P < .01)。
- 末次随访时,HHS、JOA髋关节疾病评估问卷各域、Oxford髋关节评分和Short Form-36两组间无差异。
- UCLA评分和并发症率相当:CVO组3%,THA组7%。
- 以任何原因手术为终点的10年生存率相当:CVO组91.8%,THA组97.7%。
临床怎么用
- 在严格掌握适应证的前提下,CVO可作为50岁以下ONFH患者保留髋关节的治疗选择,长期功能与THA相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Given recent advances in total hip arthroplasty (THA), curved intertrochanteric varus osteotomy (CVO) is not indicated as a treatment for osteonecrosis of the femoral head (ONFH), unless indicated to maintain long-term hip function and achieve patient satisfaction. We aimed to compare the clinical outcomes of CVO with those of THA for treatment of ONFH in young adults <50 years old. METHODS: This comparative study included 105 ONFH patients: 59 patients (65 hips) who underwent CVO and 46 patients (56 hips) who underwent THA. Assessment tools included the Harris hip score (HHS), patient-reported outcomes of the Short Form-36, Oxford hip score, Japanese Orthopaedic Association Hip-Disease Evaluation Questionnaire, and University of California, Los Angeles score, together with complication and survival rates. RESULTS: Preoperative HHS was significantly higher in the CVO group than in the THA group (P < .01). At the last follow-up, no between-group differences were noted in HHS, all domains of Japanese Orthopaedic Association Hip-Disease Evaluation Questionnaire scores, Oxford hip score, and Short Form-36. University of California, Los Angeles scores and complication rates were comparable: 3% for the CVO and 7% for the THA group. The 10-year survival rate with surgery for any reason as the end point was comparable, at 91.8% for the CVO and 97.7% for the THA group. CONCLUSION: Functional outcomes, survival rate, and sporting activities for patients <50 years old undergoing CVO or THA for ONFH were comparable after a mean follow-up period of 10 years. Strict indications for CVO can help maintain hip function and patient satisfaction equivalent to that for THA, in the long term.
引用
- Osawa Y, Seki T, Okura T, et al. Curved Intertrochanteric Varus Osteotomy vs Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients Under 50 Years Old. J Arthroplasty. 2020. PMID: 32063410. doi:10.1016/j.arth.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。